GLI2 Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band 167.8 kDa observed
Observed band 167.8 kDa observed
Gel 8-10%
Positive control Breast
Negative control Soft tissue
Important caveats
Reasons your observed band may differ from the expected size.
Calculated mass167.8 kDa
LocalizationNucleus / Cytoplasm
Processing / PTMRecord-dependent
ReactivityHuman / Mouse / Rat
Section 1

Real Curated GLI2 Western Blot Protocols

Start with the molecular-weight rule, then compare verified publication-derived conditions.

Recommended Western blot protocol parameters
Sample / lysateAdipose tissue
Gel %8-10%
Load20-30 µg total protein per lane
TransferWet/tank, extended transfer
Membrane0.45 µm PVDF
Blocking5% non-fat milk or 5% BSA in TBST
PrimaryA00701-5 at datasheet starting dilution
Primary incubationOvernight at 4 °C with gentle agitation
SecondarySpecies-matched HRP conjugate at validated dilution
Wash3 × 5 min in TBST
DetectionChemiluminescent substrate
ExposureBracket exposures to avoid saturation
Section 2

What Is the Expected GLI2 Western Blot Band Size?

Use the product-observed 167.8 kDa band as the primary planning value and retain the UniProt calculated mass as context.

What am I looking at on my blot?
167.8 kDaMatches the authoritative product WB observation.
167.8 kDa calculatedUse as UniProt context, not as a replacement observed band.
Unexpected additional signalDo not assign identity without orthogonal positive/negative controls.
💡Expected GLI2 appearancePlan around 167.8 kDa and keep the calculated mass as supporting context.
How each factor affects band size
Catalog-observed band167.8 kDa; use this as the primary experimental expectation.
Calculated mass167.8 kDa from UniProt P10070; retain as context.
Gel selection8-10%; shared with the recommended protocol and poster.
Specificity checkCompare the lead HPA positive and negative controls with A00701-5.
Why is my band missing or off?
SituationLikely causeNext action
167.8 kDaMatches the authoritative product WB observation.Confirm with orthogonal controls and the linked product record.
Additional bandMay reflect processing, modification, or non-specific signal.Run a dilution series and compare positive/negative controls.
Weak signalTarget abundance or transfer may be limiting.Verify transfer, increase positive-control abundance, and bracket exposure.

Sample controls for GLI2 Western blot

🧪Use Breast as the first positive-control candidate and retain an orthogonal negative control.
Positive control: Breast (High)
Negative control: Soft tissue (Not detected)
HPA protein score determines control status; other expression data is supporting context only.

HPA tissue expression evidence for GLI2

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart on each tissue page — click any row's HPA link to view the source.

Positive expression · recommended positive controls

Tissue Cell type Level Evidence Source
Breast Reported tissue cells High Protein (HPA) HPA →
Adipose tissue Reported tissue cells High Protein (HPA) HPA →
Adrenal gland Reported tissue cells High Protein (HPA) HPA →
Appendix Reported tissue cells High Protein (HPA) HPA →
Appendix Reported tissue cells High Protein (HPA) HPA →

Undetected expression · recommended negative controls

Tissue Cell type Level Evidence Source
Soft tissue Reported tissue cells Not detected Protein (HPA) HPA →
Section 3

Advanced GLI2 Western Blot Tips

Deeper troubleshooting and optimisation questions for GLI2, answered from its protein features.

Which band should guide the blot?
Use 167.8 kDa, the observation attached to the authoritative A00701-5 WB record.
How should calculated mass be interpreted?
Treat the UniProt calculated mass as context; it does not replace the catalog-observed 167.8 kDa expectation.
Which positive control should I start with?
Start with Breast, the lead HPA protein-expression candidate.
Which negative control is defensible?
Use Soft tissue as an orthogonal HPA Not detected candidate.
Which gel should I use?
Use 8-10% consistently across the quick facts, protocol table, and poster.
What transfer method to use for GLI2 Western blot?
Use the transfer method in the recommended protocol and verify transfer before blocking.
How should A00701-5 be started?
Start at the linked datasheet condition and run a three-point primary-antibody dilution test.
Which publication-derived protocols can I compare?
No verified publication protocol was supplied; use only the deterministic recommended protocol.
Boster reagents

GLI2 Western Blot Reagents

Human/Mouse/Rat-reactive GLI2 Western blot reagents with authoritative product imagery.

Real WB dataWestern blot validation image for GLI2 using A00701-5; observed band 167.8 kDa
Anti-Zinc finger protein GLI2 GLI2 Antibody Picoband®
Cat # A00701-5
Real WB dataWestern blot validation image for GLI2 using A00701-6; observed band 167.8 kDa
Anti-GLI2 Antibody Picoband®
Cat # A00701-6
Real WB dataWestern blot validation image for GLI2 using PA1941; observed band 167.8 kDa
Anti-Zinc finger protein GLI2 Gli2 Antibody Picoband®
Cat # PA1941

Only image-backed, WB-validated Human/Mouse/Rat recommendations from the prepared catalog evidence are shown.

Source: prepared picoband-wb product evidence; each card retains its own SKU, URL, observed band, and authoritative WB image.